1. Home
  2. STXS vs CNTN Comparison

STXS vs CNTN Comparison

Compare STXS & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.62

Market Cap

183.7M

Sector

Health Care

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.73

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STXS
CNTN
Founded
1990
2017
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.7M
185.3M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
STXS
CNTN
Price
$1.62
$2.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
382.4K
1.2M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
16.67
N/A
EPS
N/A
N/A
Revenue
$29,346,617.00
N/A
Revenue This Year
$28.22
N/A
Revenue Next Year
$30.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$2.14
52 Week High
$3.59
$5.27

Technical Indicators

Market Signals
Indicator
STXS
CNTN
Relative Strength Index (RSI) 34.40 42.09
Support Level N/A $2.14
Resistance Level $1.99 $3.80
Average True Range (ATR) 0.10 0.35
MACD -0.02 -0.00
Stochastic Oscillator 3.95 33.65

Price Performance

Historical Comparison
STXS
CNTN

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: